Investors

Analyst Coverage

FirmAnalystPhone
Bank of AmericaKatharine  Kim212-583-8337
Barclays CapitalJim  Birchenough415-274-5393
BMOJason  Zhang212-885-4179
Cowen and CompanyEric  Schmidt646-562-1345
Goldman SachsMay-Kin  Ho212-902-6723
JP MorganGeoffrey Meacham212-622-6531
Lazard & Co., LtdJoel Sendek212-632-1926
Leerink SwannHoward  Liang617-918-4857
Merrill LynchTom  McGahren 212-449-3462
Morgan StanleySteven Harr212-761-3805
Piper JaffrayCaroline Stewart212-284-9324
Rodman & RenshawChris  James212-430-1787
Stanford GroupHan  Li212-372-6373
SusquehannaDerek  Jellinek212-514-4857
Thomas Weizel Stephen  Willey212-271-3620
UBS Maged  Shenouda212-713-3982
OSI Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding OSI Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of OSI Pharmaceuticals, Inc. or its management. OSI Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.